Moderna’s announcement comes at a time when wealthy nations and vaccine makers face intense criticism for failing to deliver adequate vaccine doses to poorer nations.
Moderna has reached an agreement to sell up to 110 million shots of its Covid-19 vaccine to member nations of the African Union, the drugmaker announced on Tuesday, a move that comes at a time when vaccine makers and wealthy nations face increasing pressure to fulfill their commitments to poorer nations whose vaccination rates are vastly lower.criticism for failing to deliver adequate vaccine doses to poorer nations.
The company said it’s working on plans to bottle doses of its vaccine in Africa sometime in 2023 and is also working to build an mRNA vaccine manufacturing facility in the continent. Moderna’s fresh commitment is on top of its existing commitment to supply 500 million vaccine doses through 2022 to the WHO-backed Covax program, which was created to ensure equitable vaccine access, but that has since been criticized for14%. That’s the percentage of the 1.
last week by the People’s Vaccine Alliance. The report noted that Moderna has not delivered any of the vaccines it has pledged to Covax.Tuesday’s agreement comes as Moderna faces growing criticism for not sharing its vaccine recipe or transferring its technology to manufacturers in poorer nations who could manufacture doses of its vaccine for their local markets.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC Recommends Booster Shots For All 3 Covid Vaccines — But Not Everyone Is EligibleMillions of fully vaccinated Americans will now be able to take an extra Covid-19 vaccine dose — but eligibility depends on the vaccine.
Read more »
Moderna Reports COVID-19 Vaccine Safe and Efficacious for KidsThe company plans to submit a request to authorize the vaccine for children ages 6 to 11 years old
Read more »
Moderna says its Covid vaccine has strong results in children ages 6 to 11Data from an interim study showed two 50 microgram doses of the vaccine, half the strength of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
Read more »
Moderna says its COVID-19 vaccine protective, safe in young childrenModerna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, and the company plans to submit the data to regulators soon.
Read more »
Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
Read more »
Europe drug regulator backs use of Moderna's COVID-19 booster vaccineThe European Union's drug regulator on Monday said it has concluded in its review that Moderna's COVID-19 booster vaccine may be given to people aged 18 years and above, at least six months after the second dose.
Read more »